DE3783305D1 - Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i. - Google Patents

Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.

Info

Publication number
DE3783305D1
DE3783305D1 DE8787114733T DE3783305T DE3783305D1 DE 3783305 D1 DE3783305 D1 DE 3783305D1 DE 8787114733 T DE8787114733 T DE 8787114733T DE 3783305 T DE3783305 T DE 3783305T DE 3783305 D1 DE3783305 D1 DE 3783305D1
Authority
DE
Germany
Prior art keywords
expression vector
igf
growth factor
met
insuline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787114733T
Other languages
English (en)
Other versions
DE3783305T2 (de
Inventor
Ueda Ikuo
Niwa Mineo
Saito Yoshimasa
Ishii Yoshinori
Kitaguchi Tadashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3783305D1 publication Critical patent/DE3783305D1/de
Publication of DE3783305T2 publication Critical patent/DE3783305T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE8787114733T 1986-10-09 1987-10-08 Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i. Expired - Fee Related DE3783305T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24070286 1986-10-09

Publications (2)

Publication Number Publication Date
DE3783305D1 true DE3783305D1 (de) 1993-02-11
DE3783305T2 DE3783305T2 (de) 1993-05-19

Family

ID=17063431

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787114733T Expired - Fee Related DE3783305T2 (de) 1986-10-09 1987-10-08 Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.

Country Status (5)

Country Link
EP (1) EP0264074B1 (de)
AT (1) ATE84065T1 (de)
DE (1) DE3783305T2 (de)
ES (1) ES2044887T3 (de)
GR (1) GR3007491T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd ｈＥＧＦの製法
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
JP3377524B2 (ja) * 1990-05-30 2003-02-17 プレジデント アンド フェロウズ オブ ハーバード カレッジ 創傷治癒
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
WO1996007744A1 (en) * 1994-09-08 1996-03-14 Chiron Corporation A method of improved production of insulin-like growth factor
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
EP0440311A1 (de) * 1985-06-20 1991-08-07 Fujisawa Pharmaceutical Co., Ltd. Herstellungsverfahren für menschliches alpha-Atrio-natriuretisches Polypeptid

Also Published As

Publication number Publication date
GR3007491T3 (de) 1993-07-30
EP0264074A2 (de) 1988-04-20
ATE84065T1 (de) 1993-01-15
DE3783305T2 (de) 1993-05-19
EP0264074A3 (en) 1989-10-25
ES2044887T3 (es) 1994-01-16
EP0264074B1 (de) 1992-12-30

Similar Documents

Publication Publication Date Title
EP0244234A3 (en) Transformation of trichoderma
CZ738982A3 (en) Human immune interferon and derivative thereof, separated dna with sequence encoding human immune interferon, recombinant cloning vector, replicable expression vector, recombinant micro-organism or cellular culture, pharmaceutical preparation, process for preparing the human immune interferon and its use
IL83192A0 (en) Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
HUP9903856A2 (hu) Új Escherichia coli törzsek,eljárások előállításukra és felhasználásuk fermentációs folyamatokban L-treonin előállítására
AU6733487A (en) Mammalian interleukin-4
IT1223334B (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
DE69229572D1 (de) Gliazellen-aktivierender Faktor und dessen Herstellung
GR3015741T3 (en) Antifungal polypeptide, process for producing it.
ZA918462B (en) Expression system.
ZA887773B (en) Interleukin-7
AU3329989A (en) Viper venom polypeptides and genetic expression
DE3783305D1 (de) Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.
AU4683489A (en) Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
EP0643133A3 (de) Rekombinante D-Hydantoinase, Verfahren zur Herstellung und Verwendung.
AU7151687A (en) Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
NO175318C (no) Hybridgen for veksthormonfrigjörende faktor, replikerbar mikrobiell ekspresjonsvektor inneholdende et slikt gen, samt mikroorganisme transformert med en slik vektor og hybridpolypeptid som inneholder en Trp-GRF
ATE46537T1 (de) Promotor und dessen verwendung.
DK502786A (da) Fremgangsmaade til fremstilling af en vaekstfaktor
IT1202612B (it) Plasmidi ricombinanti utili per l'espressione in bacillus di proteine eterologhe
ES8801378A1 (es) Un metodo para preparar un vector de expresion que tiene un sistema de replicacion funcional en un microorganismo hospedante
IL82736A0 (en) Composite dna sequence,vectors,cells and bacterial strains comprising it and their use for the production of growth hormone
WO1994013800A3 (en) Mk protein preparation and use in cell culture
ES2075028T3 (es) Procedimiento para la preparacion de tripeptidos.
CA2058785A1 (en) Method of producing proteins with fviii activity and/or fviii derivatives
ZA875267B (en) Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee